XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Common Shares
Offering
Common Shares
Additional Paid in Capital
Accumulated Deficit
Noncontrolling Interest
Offering
Total
Beginning Balance at Sep. 30, 2022   $ 645 $ 305,411,272 $ (292,500,088) $ (2,890)   $ 12,908,939
Beginning Balance (in shares) at Sep. 30, 2022   645,426          
Increase (Decrease) in Stockholders' Equity              
Stock based compensation expense     93,748       93,748
Net income (loss)       (3,843,372) (874)   (3,844,246)
Ending Balance at Dec. 31, 2022   $ 645 305,505,020 (296,343,460) (3,764)   9,158,441
Ending Balance (in shares) at Dec. 31, 2022   645,426          
Beginning Balance at Sep. 30, 2022   $ 645 305,411,272 (292,500,088) (2,890)   12,908,939
Beginning Balance (in shares) at Sep. 30, 2022   645,426          
Increase (Decrease) in Stockholders' Equity              
Net income (loss)             (6,407,265)
Ending Balance at Jun. 30, 2023   $ 645 306,103,666 (298,854,883) (55,360)   7,194,068
Ending Balance (in shares) at Jun. 30, 2023   645,426          
Beginning Balance at Dec. 31, 2022   $ 645 305,505,020 (296,343,460) (3,764)   9,158,441
Beginning Balance (in shares) at Dec. 31, 2022   645,426          
Increase (Decrease) in Stockholders' Equity              
Stock based compensation expense     258,604       258,604
Net income (loss)       588,343 (37,167)   551,176
Ending Balance at Mar. 31, 2023   $ 645 305,763,624 (295,755,117) (40,931)   9,968,221
Ending Balance (in shares) at Mar. 31, 2023   645,426          
Increase (Decrease) in Stockholders' Equity              
Stock based compensation expense     340,042       340,042
Net income (loss)       (3,099,766) (14,429)   (3,114,195)
Ending Balance at Jun. 30, 2023   $ 645 306,103,666 (298,854,883) (55,360)   7,194,068
Ending Balance (in shares) at Jun. 30, 2023   645,426          
Beginning Balance at Sep. 30, 2023   $ 683 307,397,623 (302,447,147) (78,747)   $ 4,872,412
Beginning Balance (in shares) at Sep. 30, 2023   682,926         682,926
Increase (Decrease) in Stockholders' Equity              
Exercise of options cashlessly   $ 1 (1)        
Exercise of options cashlessly (in shares)   105          
Common stock issued   $ 4 45,562       $ 45,566
Common stock issued (In shares)   4,397          
Stock based compensation expense     340,705       340,705
Deemed dividend - warrant repricing     77,757 (77,757)      
Net income (loss)       (1,105,100) (25,181)   (1,130,281)
Ending Balance at Dec. 31, 2023   $ 688 307,861,646 (303,630,004) (103,928)   4,128,402
Ending Balance (in shares) at Dec. 31, 2023   687,428          
Beginning Balance at Sep. 30, 2023   $ 683 307,397,623 (302,447,147) (78,747)   $ 4,872,412
Beginning Balance (in shares) at Sep. 30, 2023   682,926         682,926
Increase (Decrease) in Stockholders' Equity              
Common stock issued (In shares)             4,501
Deemed dividend - warrant repricing           $ 155,330  
Net income (loss)             $ (3,774,563)
Ending Balance at Jun. 30, 2024   $ 10,301 318,757,698 (306,376,012) (157,532)   $ 12,234,455
Ending Balance (in shares) at Jun. 30, 2024   10,299,385         10,299,384
Beginning Balance at Dec. 31, 2023   $ 688 307,861,646 (303,630,004) (103,928)   $ 4,128,402
Beginning Balance (in shares) at Dec. 31, 2023   687,428          
Increase (Decrease) in Stockholders' Equity              
Common stock issued $ 161 $ 1 18,830     $ 161 18,831
Common stock issued (In shares) 161,403 105          
Stock based compensation expense     171,004       171,004
Share issued upon restricted stock vesting   $ 14 (14)        
Share issued upon restricted stock vesting (in shares)   14,132          
Deemed dividend - warrant repricing     155,330 (155,330)      
Net income (loss)       (4,470,474) (23,309)   (4,493,783)
Ending Balance at Mar. 31, 2024   $ 864 308,206,796 (308,255,808) (127,237)   (175,385)
Ending Balance (in shares) at Mar. 31, 2024   863,068          
Increase (Decrease) in Stockholders' Equity              
Common stock and pre-funded warrants issued in public offering, net of offering costs   $ 725 10,524,338       10,525,063
Common stock and pre-funded warrants issued in public offering, net of offering costs (in shares)   724,923          
Stock based compensation expense     30,336       30,336
Share issued upon warrant exercises (in Shares)   8,626,333          
Share issued upon warrant exercises   $ 8,627 (3,687)       4,940
Adjustment for reverse split   $ 85 (85)        
Adjustment for reverse split (in Shares)   85,061          
Net income (loss)       1,879,796 (30,295)   1,849,501
Ending Balance at Jun. 30, 2024   $ 10,301 $ 318,757,698 $ (306,376,012) $ (157,532)   $ 12,234,455
Ending Balance (in shares) at Jun. 30, 2024   10,299,385         10,299,384